Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients.
暂无分享,去创建一个
[1] N. Savion,et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. , 1997, Thrombosis research.
[2] K. Fox,et al. Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina. , 1997, Circulation.
[3] C. Yosefy,et al. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis. , 1996, Journal of human hypertension.
[4] J. Moake,et al. Platelets and shear stress. , 1996, Blood.
[5] M. Muggeo,et al. Cardiovascular Disease and Its Risk Factors in IDDM in Europe , 1996, Diabetes Care.
[6] Z. Bloomgarden,et al. Potential mechanisms promoting restenosis in diabetic patients. , 1996, Journal of the American College of Cardiology.
[7] F. Gries,et al. Exposure of Adhesion Molecules on Activated Platelets in Patients with Newly Diagnosed IDDM Is Not Normalized by Near-Normoglycemia , 1995, Diabetes.
[8] M B Brown,et al. A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.
[9] Epic Investigators,et al. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.
[10] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[11] U. Cogan,et al. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. , 1994, Metabolism: clinical and experimental.
[12] J. Yudkin,et al. “Spontaneous” Platelet Aggregation in Whole Blood in Diabetic and Non Diabetic Survivors of Acute Myocardial Infarction , 1993, Thrombosis and Haemostasis.
[13] D. Baim,et al. Restenosis after Arterial Injury Caused by Coronary Stenting in Patients with Diabetes Mellitus , 1993, Annals of Internal Medicine.
[14] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[15] Charles L. Brown,et al. Can restenosis after coronary angioplasty be predicted from clinical variables? , 1993, Journal of the American College of Cardiology.
[16] J. Akkerman,et al. The influence of lipoproteins on blood platelets. , 1993, American heart journal.
[17] F. Gries,et al. Platelets in Diabetes: The Role in the Hemostatic Regulation in Atherosclerosis , 1993, Seminars in thrombosis and hemostasis.
[18] P. Winocour. Platelet Abnormalities in Diabetes Mellitus , 1992, Diabetes.
[19] F. Ferris. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. , 1992, JAMA.
[20] D. Bareford,et al. The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension , 1992, Journal of hypertension.
[21] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[22] J. Muller,et al. Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men. , 1992, The American journal of cardiology.
[23] K Watanabe,et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. , 1991, The Journal of clinical investigation.
[24] D. Betterridge,et al. Comparison of the Effects of Carvedilol, Propranolol, and Verapamil on in vitro Platelet Function in Healthy Volunteers , 1991, Journal of cardiovascular pharmacology.
[25] P. Elwood,et al. Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. , 1991, Circulation.
[26] J. Schapiro,et al. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. , 1990, The New England journal of medicine.
[27] B. Clarke,et al. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients. , 1989, Diabete & metabolisme.
[28] A. Remaley,et al. Evaluation of the clinical utility of platelet aggregation studies , 1989, American journal of hematology.
[29] A. Barrett,et al. Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia , 1989 .
[30] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[31] S. Feman,et al. Thromboxane biosynthesis and platelet function in type I diabetes mellitus. , 1988, The New England journal of medicine.
[32] M. Aviram,et al. Platelet Lipoprotein Interactions , 1988, Seminars in thrombosis and hemostasis.
[33] B. Howard,et al. Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.
[34] P. Halushka,et al. Do Platelets Have Anything To Do With Diabetic Microvascular Disease? , 1983, Diabetes.
[35] J. P. Moulin,et al. ABNORMALITIES OF ERYTHROCYTE DEFORMABILITY AND PLATELET AGGREGATION IN INSULIN-DEPENDENT DIABETICS CORRECTED BY INSULIN IN VIVO AND IN VITRO , 1982, The Lancet.
[36] P. Halushka,et al. PLATELET FUNCTION IN DIABETES MELLITUS , 1980, British journal of haematology.
[37] P. Steele,et al. Effects of Dietary and Pharmacologic Alteration of Serum Lipids on Platelet Survival Time , 1978, Circulation.
[38] A. Basten,et al. Letter: Lupus erythematosus and brain scanning. , 1975, Annals of internal medicine.
[39] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .
[40] H. Kwaan,et al. Increased platelet aggregation in diabetes mellitus. , 1972, The Journal of laboratory and clinical medicine.
[41] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.